Effect of 4 Weeks Treatment With Acipimox in Patients With Chronic Heart Failure
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate whether metabolic modulation improves left
ventricular function, work capacity, insulin sensitivity and modifies substrate metabolism in
chronic heart failure